Drug Type Small molecule drug |
Synonyms 注射用HLN601脂质体 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 11 Dec 2024 | |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 11 Dec 2024 | |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 11 Dec 2024 | |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 11 Dec 2024 | |
Breast Cancer | IND Approval | CN | 26 Feb 2024 | |
Breast Cancer | IND Approval | CN | 26 Feb 2024 | |
Breast Cancer | IND Approval | CN | 26 Feb 2024 | |
Colorectal Cancer | IND Approval | CN | 26 Feb 2024 | |
Colorectal Cancer | IND Approval | CN | 26 Feb 2024 | |
Colorectal Cancer | IND Approval | CN | 26 Feb 2024 |